APOB and hypertriglyceridemia: We further reported that plasma apoB, but not LDL-cholesterol (LDL-C), predicted white adipose tissue (WAT) dysfunction and related risk factors for T2D including elevated glucose-induced insulin secretion (GIIS), insulin resistance (IR), systemic inflammation, and postprandial hypertriglyceridemia independently of sex and adiposity1–6.